These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 714054)

  • 21. Short-term progestogen treatment of endometrial carcinoma. Histological, histochemical and hormonal studies.
    Moe N
    Acta Obstet Gynecol Scand; 1972; 51(1):55-62. PubMed ID: 4261828
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroxyprogesterone caproate therapy in advanced endometrial cancer.
    Reifenstein EC
    Cancer; 1971 Mar; 27(3):485-502. PubMed ID: 5549492
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peculiar secretory activity of endometrial cancer cells during progestational therapy].
    Szarvas Z
    Morphol Igazsagugyi Orv Sz; 1978 Apr; 18(2):101-6. PubMed ID: 714043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy.
    Wilkinson EJ; Friedrich EG; Mattingly RF; Regali JA; Garancis JC
    Obstet Gynecol; 1973 Aug; 42(2):193-200. PubMed ID: 4721406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.
    Reifenstein EC
    Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment with high doses of progestational agents in endometrial adenocarcinoma].
    Goisis M; Servida E; Goisis F
    Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormonal treatment of endometrial carcinoma.
    Nilsen PA
    Acta Obstet Gynecol Scand; 1969; 48(S3):120-1. PubMed ID: 5380812
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of high dosage progesterone therapy in carcinoma corporis uteri].
    Seewald HJ; Böhm W; Przesang R
    Zentralbl Gynakol; 1977; 99(7):392-5. PubMed ID: 868363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
    Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS
    Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650
    [No Abstract]   [Full Text] [Related]  

  • 30. The histological changes produced in untreated adeno-carcinoma of the endometrium by a progestogen.
    Hudson CN; Stansfeld AG
    J Obstet Gynaecol Br Commonw; 1967 Jun; 74(3):442-4. PubMed ID: 6026619
    [No Abstract]   [Full Text] [Related]  

  • 31. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intramitochondrial changes in adenocarcinoma cells of the uterine mucosa following progesterone therapy].
    Szarvas Z
    Morphol Igazsagugyi Orv Sz; 1980 Apr; 20(2):81-7. PubMed ID: 7266506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy and endocrine therapy of endometrial carcinoma].
    Kanuma T; Matsuzawa M
    Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of progestational agents in the management of metastatic carcinoma of the endometrium.
    Kistner RW; Griffiths CT
    Clin Obstet Gynecol; 1968 Jun; 11(2):439-56. PubMed ID: 4879374
    [No Abstract]   [Full Text] [Related]  

  • 38. 6-alpha-methyl- 17-alpha-hydroxyprogesterone acetate as a chemotherapeutic agent in adenocarcinoma of the uterus.
    Bonte JB; Drochmans A; Ide P
    Acta Obstet Gynecol Scand; 1966; 45(1):121-9. PubMed ID: 4160834
    [No Abstract]   [Full Text] [Related]  

  • 39. [Progestational hormones in the treatment of gynecologic cancers].
    Soutoul JH; Lagabrielle V
    Presse Med (1893); 1969 Feb; 77(7):247-9. PubMed ID: 5795418
    [No Abstract]   [Full Text] [Related]  

  • 40. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.